// App-Quantinova.ai

S105 : DYSREGULATION OF CHROMATIN MODIFIERS DRIVES LINEAGE SWITCH IN MLL-R ACUTE LEUKEMIA

Researchers

Presenter

  • Ricky Tirtakusuma

Principal Investigators

  • Katarzyna Szoltysek

  • Paul Milne

  • Vasily V. Grinev

  • Helen Blair

  • Sirintra Nakjang

  • Anetta Ptasinska

  • Salam Assi

  • Claus Meyer

  • Rolf Marschalek

  • James Allan

  • Josef Vormoor

  • Constanze Bonifer

  • Simon Bomken

  • Olaf Heidenreich

Medical Centers

  • Goethe University, Frankfurt, Germany

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • University of Birmingham, Birmingham, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Princess Maxima Center, Utrecht, Netherlands

  • Belarusian State Medical University, Minsk, Belarus

Locations

  • Germany

  • Spain

  • United Kingdom

  • Netherlands

  • Belarus

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute Leukemia

Biomarkers

  • Cluster of Differentiation 34

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved